Elevance Health 2024 Profits Hit $6 Billion Despite Rising Costs
Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer worked to overcome rising medical expenses.
Elevance Health expects to grow MA membership by at least 7% in 2025
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,
Elevance Health Stock Rises as Company Tops Estimates, Raises Dividend
Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, acquisitions, and growth in its pharmacy division.
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for standing by,
Elevance Health (ELV) Initiated with a Buy at Cantor Fitzgerald
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
UPDATE: Elevance Health shares tick up on better-than-expected earnings
Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market trading Thursday. Shares of Elevance gained more than 4% to $408 a share before the bell.
Why Is Elevance Health, Inc. (ELV) Among the Best Large-Cap Value Stocks to Buy in 2025?
We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other large-cap value stocks.
Elevance Health (ELV) Receives a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a
Elevance Health (ELV) Q4 2024 Earnings Call Transcript
Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.
Elevance Health reports Q4 adjusted EPS $3.84, consensus $3.86
Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we
Managed Care Insurers Get Wall Street Bump Even With Mixed Q4 2024 Results
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Modern Healthcare3d
Elevance Health expects high Medicaid costs to drop in 2025
Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...
Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...
Ann Hynes Recommends ‘Buy’ on Elevance Health Due to Strong Growth Potential and Strategic Guidance
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on ELV stock, giving a Buy rating on January 16.Invest with ...